Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 23 Similar Profiles
Lymphoma, Large B-Cell, Diffuse
Medicine & Life Sciences
Non-Hodgkin's Lymphoma
Medicine & Life Sciences
Lymphoma
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Follicular Lymphoma
Medicine & Life Sciences
Disease-Free Survival
Medicine & Life Sciences
B-Cell Lymphoma
Medicine & Life Sciences
Hodgkin Disease
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1978 2017
- 2 Finished
Lymphoma Specialized Program of Research Excellence
Macon, W. R., Dogan, A. M., Ansell, S. M., Gupta, M. D., Witzig, T. E., Cerhan, J. R., Habermann, T. M., Ratliff, T. L., Link, B. K., Ratliff, T. L., Juweid, M., Ballas, Z., Link, B. K., Ratliff, T., Geyer, S. M., Weiner, G., Lentz, S., Hohl, R. & Smith, B. J.
9/11/02 → 6/30/17
Project: Research project
Lymphoma
Non-Hodgkin's Lymphoma
Molecular Epidemiology
B-Lymphocytes
B-Cell Lymphoma
EASTERN COOPERATIVE ONCOLOGY GROUP
Habermann, T. M., Hahn, R. & Edmonson, J.
6/1/78 → 4/30/16
Project: Research project
Antineoplastic Protocols
Organized Financing
Neoplasms
Research
Clinical Protocols
Research Output 1983 2019
Cause of death in follicular lymphoma in the first decade of the rituximab era: A pooled analysis of French and US cohorts
Sarkozy, C., Maurer, M. J., Link, B. K., Ghesquieres, H., Nicolas, E., Thompson, C. A., Traverse-Glehen, A., Feldman, A. L., Allmer, C., Slager, S. L., Ansell, S. M., Habermann, T. M., Bachy, E., Cerhan, J. R. & Salles, G., Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 144-152 9 p.Research output: Contribution to journal › Article
Follicular Lymphoma
Cause of Death
Lymphoma
Disease-Free Survival
Rituximab
Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study
Wang, Y., Habermann, T. M., Wang, S. S., Maurer, M. J., Sarangi, V., Link, B. K., Feldman, A. L., Inwards, D. J., Witzig, T. E., Cozen, W., Rothman, N., Asmann, Y., Slager, S. L. & Cerhan, J. R., Jan 1 2019, In : American journal of hematology.Research output: Contribution to journal › Letter
Open Access
Mantle-Cell Lymphoma
Tumor Necrosis Factor-alpha
2
Citations
(Scopus)
Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma
Hill, B. T., Nastoupil, L., Winter, A. M., Becnel, M. R., Cerhan, J. R., Habermann, T. M., Link, B. K., Maurer, M. J., Fakhri, B., Reddy, P., Smith, S. D., Mukhija, D., Jagadeesh, D., Desai, A., Alderuccio, J. P., Lossos, I. S., Mehra, P., Portell, C. A., Goldman, M. L., Calzada, O. & 9 others, Feb 1 2019, In : British Journal of Haematology. 184, 4, p. 524-535 12 p.Research output: Contribution to journal › Article
Follicular Lymphoma
Maintenance
Observation
Therapeutics
Vincristine
Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galiën et al
Maurer, M. J. & Habermann, T. M., Jan 1 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, 1, 1 p.Research output: Contribution to journal › Article
Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
1
Citation
(Scopus)
Acute coronary syndromes in patients with active hematologic malignancies – Incidence, management, and outcomes
Park, J. Y., Guo, W., Al-Hijji, M., El Sabbagh, A., Begna, K. H., Habermann, T. M., Witzig, T. E., Lewis, B. R., Lerman, A. & Herrmann, J., Jan 1 2018, (Accepted/In press) In : International Journal of Cardiology.Research output: Contribution to journal › Article
Hematologic Neoplasms
Acute Coronary Syndrome
Incidence
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Troponin